IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.066
EU - Europa 1.951
AS - Asia 784
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
SA - Sud America 1
Totale 4.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.049
IT - Italia 616
CN - Cina 563
SE - Svezia 442
IE - Irlanda 419
FI - Finlandia 202
SG - Singapore 126
DE - Germania 87
UA - Ucraina 56
TR - Turchia 55
GB - Regno Unito 47
FR - Francia 36
BE - Belgio 25
CA - Canada 17
IN - India 15
CI - Costa d'Avorio 10
HK - Hong Kong 8
IR - Iran 7
EU - Europa 6
PK - Pakistan 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 3
ES - Italia 3
NL - Olanda 3
AT - Austria 2
KE - Kenya 2
PT - Portogallo 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
EG - Egitto 1
JP - Giappone 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 4.824
Salva come PNG Salva come JPEG
Città #
Dublin 408
Chandler 376
Ann Arbor 172
Parma 170
Ashburn 144
Dearborn 142
Boardman 137
Beijing 129
Jacksonville 83
Shanghai 80
Nanjing 78
Singapore 78
Princeton 69
Izmir 53
New York 52
Wilmington 43
Los Angeles 29
Helsinki 28
Jinan 28
Nanchang 28
San Mateo 26
Shenyang 26
Woodbridge 25
Brussels 24
Kunming 22
Des Moines 21
Bologna 20
Hebei 18
Changsha 16
Colchester 15
Hangzhou 15
Hefei 15
Santa Clara 15
Falls Church 14
Tianjin 14
Guangzhou 13
Redmond 13
Seattle 13
Toronto 12
Fontanellato 11
Milan 11
Abidjan 10
Piacenza 10
Rome 10
Bremen 9
Houston 9
Pistoia 9
Zhengzhou 9
Bari 8
Dallas 8
Norwalk 8
Pune 8
Vicenza 8
Gravina di Catania 7
Vezzano sul Crostolo 7
Dosolo 6
Haikou 6
Washington 6
Grafing 5
Langhirano 5
Mardan 5
Newcastle Upon Tyne 5
Reggio Nell'emilia 5
Trezzano Sul Naviglio 5
Arnstadt 4
Avola 4
Brescia 4
Cagliari 4
Carpi 4
Ferrara 4
Jiaxing 4
Messina 4
Ottawa 4
Ravenna 4
Redwood City 4
Scafati 4
Zanjan 4
Chengdu 3
Este 3
Fremont 3
Fuzhou 3
Modena 3
Ningbo 3
Peterborough 3
Phoenix 3
Reggio Emilia 3
San Giovanni Valdarno 3
Taiyuan 3
Tappahannock 3
Xian 3
Ahmedabad 2
Argelato 2
Auburn Hills 2
Bellosguardo 2
Borås 2
Cambridge 2
Castel Goffredo 2
Chongqing 2
Colledara 2
Dong Ket 2
Totale 2.965
Salva come PNG Salva come JPEG
Nome #
Yeast as a model system to shed light on the role of the human disease protein Mpv17 113
DNA polymerase [gamma] and disease: what we have learned from yeast 110
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 103
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 99
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 98
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 95
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 94
Yeast as a model system for diseases associated with defective coenzyme a metabolism 91
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 91
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 87
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 86
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 85
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 85
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 82
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 81
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 81
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 80
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 79
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 79
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 78
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 78
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 77
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 75
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 74
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 74
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 73
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 72
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 71
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 71
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 70
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 70
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 70
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 70
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 69
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 68
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 66
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 65
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 64
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 64
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 64
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 64
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 63
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 63
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 59
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 59
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 59
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 58
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 58
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 58
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 57
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 57
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 57
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 57
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 56
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 55
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 55
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 55
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 52
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 50
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 50
Role of ROS in mtDNA instability in ANT1-associated adPEO 49
Mitochondrial diseases and the role of the yeast models. 49
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 47
The power of yeast in modeling human mutations leading to mitochondrial disease 46
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 45
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 44
Novel (ovario) leukodystrophy related to AARS2 mutations 42
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 42
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 41
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 41
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 40
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 35
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 32
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 31
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 29
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 22
Yeast-based screening to discover therapies for Complex III assembly defects. 15
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 15
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 14
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 13
Epigenetic analyses in forensic medicine: future and challenges 12
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 10
Totale 5.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.487
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 0 0 37 22 48 110 78 22 75 55 23 25
2020/2021463 8 22 46 5 48 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/2025248 44 91 113 0 0 0 0 0 0 0 0 0
Totale 5.058